课题基金 / 基金详情

Selective apoptosis during treatment with superantigen and lipopolysaccharide

Selective apoptosis during treatment with superantigen and lipopolysaccharide
超抗原和脂多糖治疗期间的选择性细胞凋亡
批准号:
14571726
负责人:
RIKIISHI Hidemi
金额:
$1.79万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

RIKIISHI Hidemi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Studies of the events triggered by bacterial superantigens and lipopolysaccharide (LPS) provide rich insight into the constant battle between microbes and the oral immune system. In this study, we demonstrated a mechanism of apoptosis induced by staphylococcal enterotoxin B (SEB) in cultured monocytes and gingival fibroblasts, and some evidence for the anti-apoptotic function in CD80^+ monocytes. Apoptosis of monocytes was accelerated and enhanced by the addition of SEB. Increases in soluble CD95 ligand (sCD95L) levels were observed with stimulation with SEB, but not gamma interferon (IFN-γ). Our results clearly demonstrated that SEB treatment induces the activation of caspase-3 and -8, and pretreatment with zVAD-FMK, a broad inhibitor of caspases, prevented the induction of apoptosis at 24 h. Monocytes expressed constitutive NF-κB binding activity, and SEB further activated NF-κB, which was inhibited by pretreatment with pyrrolidine dithiocarbamate even at dose of 5 μM. PDTC markedly stimulated apoptosis induced by SEB and induced apoptosis in those treated with IFN-γ. Marked inhibition of the appearance of CD80^+ monocytes was achieved by treating cells with zVAD-FMK and DEVD-FMK, which was paralleled by reduced apoptosis of monocytes. LPS treatment resulted in significant reduction of the percentage of SEB-or IFN-γ induced apoptosis through induction of anti-apoptotic protein XIAP. Thus, our results indicated that SEB stimulation includes both anti-apoptotic actions through NF-κB activation and pro-apoptotic actions through sCD95L released by SEB, and that CD80 driven by NF-κB allows gingival tissues to participate in distinct survival programs.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
Maiko Suzuki: "Interleukin-1β converting enzyme subfamily inhibitors prevent induction of CD86 molecules by butyrate through a CREB-dependent mechanism in HL6O cells."Immunology. 108(3). 375-383 (2003)
Maiko Suzuki:“IL6O 细胞中白细胞介素 1β 转换酶亚家族抑制剂通过 CREB ​​依赖性机制阻止丁酸诱导 CD86 分子。”免疫学 108(3) 375-383 (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Suzuki: "Interleukin-1β converting enzyme subfamily inhibitors prevent induction of CD86 molecules by butyrate through a CREB-dependent mechanism in HL60 cells"Immunology. 108(3). 375-383 (2003)
M.Suzuki:“IL60 细胞中白细胞介素 1β 转换酶亚家族抑制剂通过 CREB ​​依赖性机制阻止丁酸诱导 CD86 分子”免疫学 108(3) (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H.Rikiishi: "Role of caspase in regulation of B7 costimulatory molecules of monocytic cells"Recent Research Developments in Immunology. 5. 115-129 (2003)
H.Rikiishi:“半胱天冬酶在单核细胞 B7 共刺激分子调节中的作用”免疫学的最新研究进展。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hidemi Rikiishi: "Role of caspase in regulation of B7 costimulatory molecules of monocytic cells"Recent Research Developments in Immunology. 5. 115-129 (2003)
Hidemi Rikiishi:“半胱天冬酶在单核细胞 B7 共刺激分子调节中的作用”免疫学的最新研究进展。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
10
    Mechanisms of Taxotere-induced apoptosis in or a squamous cell carcinoma.
    • 批准号:
      16390577
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $6.66万
    • 财政年份:
      2004
    • 负责人:
      RIKIISHI Hidemi
    • 依托单位:
    Inhibition of superantigen-induced apoptosis by LPS
    • 批准号:
      12671759
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2000
    • 负责人:
      RIKIISHI Hidemi
    • 依托单位:
    The etiological significance of superantigen in periodontal disease and its possible role
    • 批准号:
      10671695
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      1998
    • 负责人:
      RIKIISHI Hidemi
    • 依托单位:
    Induction of cytokines by oral bacterial stimulation and its arthropathic properties
    • 批准号:
      02670824
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1990
    • 负责人:
      RIKIISHI Hidemi
    • 依托单位:
    国内基金
    海外基金
    Lipopolysaccharide 调节 Toll-like receptor 4 介导促进心肌样细胞存活时间的实验研究
    • 批准号:
      30872544
    • 项目类别:
      面上项目
    • 资助金额:
      27.0万元
    • 批准年份:
      2008
    • 负责人:
      陈亦江
    • 依托单位: